🟢 20/20 Biolabs is trading 7.1% up in pre-market

20/20 Biolabs is trading 7.1% higher at $0.30 in pre-market, rebounding after several consecutive declining closes.

• The October 15 close was $0.28.
• No fresh company-specific announcement explaining the October 16 move was identified. The latest listed company event was participation in the Maxim Growth Summit on October 14.
• Prior coverage also described after-hours trading as lacking an identified company-specific catalyst; broader pre-market indexes were mixed.